VIJ Stock Overview Provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Add noteViemed Healthcare, Inc. Competitors Price History & Performance
Summary of share price highs, lows and changes for Viemed Healthcare Historical stock prices Current Share Price US$7.45 52 Week High US$8.95 52 Week Low US$5.55 Beta 1.46 1 Month Change -7.45% 3 Month Change 19.20% 1 Year Change 7.19% 3 Year Change 56.51% 5 Year Change 35.45% Change since IPO 19.91%
Recent News & Updates
Viemed Healthcare, Inc. Provides Revenue Guidance for the Fourth Quarter of 2024 Nov 07
Viemed Healthcare, Inc. Provides Revenue Guidance for the Third Quarter of 2024 Aug 08
Viemed Healthcare, Inc. to Report Q2, 2024 Results on Aug 08, 2024 Jul 25
Viemed Healthcare, Inc. to Report Q2, 2024 Results on Aug 08, 2024 Jul 24
Viemed Healthcare, Inc. Provides Revenue Guidance for the Second Quarter of 2024 May 08
First quarter 2024 earnings released: EPS: US$0.041 (vs US$0.04 in 1Q 2023) May 07 See more updates
Viemed Healthcare, Inc. Provides Revenue Guidance for the Fourth Quarter of 2024 Nov 07
Viemed Healthcare, Inc. Provides Revenue Guidance for the Third Quarter of 2024 Aug 08
Viemed Healthcare, Inc. to Report Q2, 2024 Results on Aug 08, 2024 Jul 25
Viemed Healthcare, Inc. to Report Q2, 2024 Results on Aug 08, 2024 Jul 24
Viemed Healthcare, Inc. Provides Revenue Guidance for the Second Quarter of 2024 May 08
First quarter 2024 earnings released: EPS: US$0.041 (vs US$0.04 in 1Q 2023) May 07 Viemed Healthcare, Inc., Annual General Meeting, Jun 06, 2024 Apr 28
Investor sentiment deteriorates as stock falls 15% Apr 09
New major risk - Revenue and earnings growth Mar 07
Full year 2023 earnings released: EPS: US$0.27 (vs US$0.16 in FY 2022) Mar 07
Viemed Healthcare, Inc. Provides Earnings Guidance for the First Quarter of 2024 Mar 07
Third quarter 2023 earnings released: EPS: US$0.076 (vs US$0.028 in 3Q 2022) Nov 02
Investor sentiment deteriorates as stock falls 15% Sep 11
Viemed Healthcare, Inc. Provides Revenue Guidance for Third Quarter of 2023 Aug 10
Second quarter 2023 earnings released: EPS: US$0.061 (vs US$0.025 in 2Q 2022) Aug 10
First quarter 2023 earnings released: EPS: US$0.04 (vs US$0.044 in 1Q 2022) May 09
Viemed Healthcare, Inc. Provides Revenue Guidance for the Second Quarter of 2023 May 09
Investor sentiment improves as stock rises 17% Mar 10
Full year 2022 earnings released: EPS: US$0.16 (vs US$0.23 in FY 2021) Mar 03
Investor sentiment improves as stock rises 15% Feb 21
Viemed Healthcare, Inc. Wins Complete Overruling of Appealed Office of Inspector General Claims Resolving Multiyear Process with HHS and CMS Jan 24
Insufficient new directors Nov 16
Viemed Healthcare, Inc. Provides Revenue Guidance for the Year 2022 Nov 05
Third quarter 2022 earnings released: EPS: US$0.028 (vs US$0.045 in 3Q 2021) Nov 03
Investor sentiment deteriorated over the past week Aug 10
Second quarter 2022 earnings released: EPS: US$0.025 (vs US$0.04 in 2Q 2021) Aug 03
Viemed Healthcare, Inc. Announces Earnings Guidance for the Third Quarter of 2022 Aug 03
Viemed Announces Management Appointments Aug 02
Investor sentiment improved over the past week Jul 09
Viemed Healthcare, Inc. Announces Publication of Peer-Reviewed NIVH Study Finding Treatment Reduces Healthcare Costs and Saves Lives Jul 06 Viemed Healthcare, Inc.(NasdaqCM:VMD) dropped from Russell 2000 Dynamic Index
First quarter 2022 earnings released: EPS: US$0.044 (vs US$0.043 in 1Q 2021) May 05
Viemed Healthcare, Inc. Provides Revenue Guidance for the Second Quarter of 2022 May 04
Insufficient new directors Apr 27
Viemed Healthcare, Inc., Annual General Meeting, Jun 09, 2022 Mar 23
Investor sentiment improved over the past week Mar 14 Viemed Healthcare, Inc. Provides Revenue Guidance for the First Quarter of 2022 Mar 10
Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat Mar 09
Third quarter 2021 earnings released: EPS US$0.045 (vs US$0.072 in 3Q 2020) Nov 02
Viemed Healthcare, Inc. Provides Earnings Guidance for the Third Quarter of 2021 Aug 05
Second quarter 2021 earnings released: EPS US$0.04 (vs US$0.50 in 2Q 2020) Aug 03
First quarter 2021 earnings released: EPS US$0.043 (vs US$0.11 in 1Q 2020) May 04
Viemed Healthcare, Inc. Provides Earnings Guidance for the Second Quarter of Fiscal 2021 May 04
Full year 2020 earnings released: EPS US$0.81 (vs US$0.23 in FY 2019) Mar 05
Revenue misses expectations Mar 05
New 90-day high: €8.80 Feb 24
Commonwealth Primary Care ACO and Viemed Healthcare Announce an Innovative Chronic Respiratory Care and Sleep Management Alliance Feb 13
New 90-day high: €8.25 Feb 04
Investor sentiment improved over the past week Feb 04
Viemed Healthcare Announces Recent Publication of Non-Invasive Ventilation Study Jan 08
Viemed Healthcare, Inc. (TSX:VMD) acquired 5% stake in VeruStat, Inc for approximately $0.6 million. Dec 23
New 90-day low: €6.65 Dec 22
Viemed Healthcare, Inc. Appoints Sabrina Heltz to the Board and to Serve on the Corporate Governance and Nominating Committee, the Audit Committee and the Compensation Committee of the Board Nov 10
Revenue beats expectations Nov 05
Third quarter 2020 earnings released: EPS US$0.072 Nov 05
New 90-day low: €6.75 Nov 03
New 90-day low - €7.45 Sep 12
First half earnings released Aug 06 Shareholder Returns VIJ DE Healthcare DE Market 7D -5.7% -3.5% -2.6% 1Y 7.2% 15.6% 6.9%
See full shareholder returns
Return vs Market: VIJ matched the German Market which returned 6.9% over the past year.
Price Volatility Is VIJ's price volatile compared to industry and market? VIJ volatility VIJ Average Weekly Movement 7.3% Healthcare Industry Average Movement 4.7% Market Average Movement 4.8% 10% most volatile stocks in DE Market 11.2% 10% least volatile stocks in DE Market 2.4%
Stable Share Price: VIJ's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: VIJ's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company Viemed Healthcare, Inc., together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment; and sells and rents HME devices.
Show more Viemed Healthcare, Inc. Fundamentals Summary How do Viemed Healthcare's earnings and revenue compare to its market cap? VIJ fundamental statistics Market cap €297.79m Earnings (TTM ) €9.99m Revenue (TTM ) €205.39m
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) VIJ income statement (TTM ) Revenue US$214.30m Cost of Revenue US$85.13m Gross Profit US$129.18m Other Expenses US$118.75m Earnings US$10.43m
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/22 19:27 End of Day Share Price 2024/12/20 00:00 Earnings 2024/09/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Viemed Healthcare, Inc. is covered by 4 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Doug Cooper Beacon Securities Limited Vadim Merkulov Freedom Broker Brooks O'Neil Lake Street Capital Markets, LLC
Show 1 more analysts